Monash BDI researchers secure $17m in NHMRC Ideas Grants
Monash Biomedicine Discovery Institute (BDI) researchers have been awarded more than $17 million to lead 17 projects in the highly competitive NHMRC Ideas Grant scheme for innovative research projects.
Awards to BDI researchers reflect the scope of research capability at the Monash BDI, everything from transforming fertility treatment and developing novel CAR T cell therapies for prostate cancer to understanding the effects of early exposure to bushfires on adult brain function and learning whether psychedelics can be used to treat anorexia nervosa.
Congratulations to all who were successful in this 2021 Ideas Grant round. It was an incredibly competitive year, and commiserations go to all those who missed out.
We acknowledge the hard work of the NHMRC in managing the peer review process and all researchers around Australia who contributed their time and expertise as peer reviewers under difficult circumstances.
The Minister for Health and Aged Care, Greg Hunt, today announced $239 million of funding in this scheme.
Congratulations to all of our researchers who have secured funding in this scheme. The 17 successful Monash BDI projects, listed with their Primary Chief Investigator, are:
- Professor Mibel Aguilar - Pathogenic membranes as therapeutic drug targets
- Professor Zane Andrews - Top down cortical control of hypothalamic feeding circuits
- Associate Professor Chen Davidovich - Rewriting the dogma of chromatin compaction: a new pathway for polycomb-mediated gene repression in development and disease
- Professor Katherine (Kate) Denton - Sex-differences in cellular aging and cardiovascular disease: Role of the AngIV/IRAP axis
- Dr Claire Foldi - Can psychedelics treat anorexia nervosa? Insights into the therapeutic effects of psilocybin in an animal model
- Associate Professor Craig Harrison - Transforming fertility treatment
- Associate Professor Tracy Heng - The mesenchymal stromal cell paradox – living cell therapy or dying therapeutic cell?
- Associate Professor Karla Hutt - Does Chlamydia infection damage the ovary and compromise fertility?
- Dr Mitchell Lawrence - ComBATing lethal prostate cancer with combination Bipolar Androgen Therapy
- Dr Sarah Lockie - Targeting the brain and sympathetic nervous system to improve outcomes in cancer cachexia
- Dr Farshad Mansouri - The effects of early exposure to bushfires on adult brain structure and function
- Professor Anthony Purcell - Dominant classes of tumour specific antigens in Melanoma
- Associate Professor Anna Roujeinikova - Elucidating the function of host-derived cysteine in bacterial virulence
- Professor Mike Ryan - Molecular mechanisms underlying the pathogenesis of complex I dysfunction and mitochondrial disease
- Professor Martin Stone - Defining chemotactic signalling networks to identify new anti-inflammatory targets
- Associate Professor Renea Taylor - Developing novel CAR T cell therapy approaches to treat prostate cancer
- Associate Professor Lee Wong - Chromatin defects in histone mutated brain cancers: from basic mechanisms to novel therapeutic strategies
Researchers from the Faculty of Medicine, Nursing and Health Sciences were awarded in excess of $35 million across 33 projects in the NHMRC Ideas Grant scheme.
Monash University received more than $41 million for 38 projects - the most of any Australian university for the second year in a row.
Read the full list of national recipients on the NHMRC site.
About the Monash Biomedicine Discovery Institute at Monash University
Committed to making the discoveries that will relieve the future burden of disease, the Monash Biomedicine Discovery Institute at Monash University brings together more than 120 internationally-renowned research teams. Our researchers are supported by world-class technology and infrastructure, and partner with industry, clinicians and researchers internationally to enhance lives through discovery.